Germany· DE-A57-ac35043cbfc6df43
Willfact
A medicinal product containing human von willebrand factor, registered in Germany by Lfb Biomedicaments.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Human Von Willebrand Factor
- Manufacturer
- Lfb Biomedicaments
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human von willebrand factor in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumHaemate P 1200 IE vWF/500 IE FVIII 1200 IU - 500 IUCSL Behring
- SpainWILLFACT 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLELfb Biomedicaments
- SwedenWillfact 1000 IE Pulver och vätska till injektionsvätska, lösningLFB-BIOMEDICAMENTS
- PolandWillfact 1000 j.m.LFB-Biomedicaments
- FranceWILFACTIN 100 UI/mL, poudre et solvant pour solution injectableLFB-BIOMEDICAMENTS
- United KingdomWillfact 1,000unit powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- CzechiaWILLFACTLFB-BIOMEDICAMENTS, Courtaboeuf
- FinlandWilfactinLFB Biomedicaments
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Willfact
- Belgium · Wilfactin
- Czechia · Willfact
- Denmark · Willfact
- Spain · Willfact
- Finland · Haemate, Wilfactin
- France · Wilfactin
- United Kingdom (Northern Ireland) · Willfact
- Greece · Haemate P, Wilfactin
- Italy · Wilfactin
- Netherlands · Wilfactin
- Norway · Willfact
- Poland · Willfact
- Sweden · Willfact
- Slovakia · Willfact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/13397207-a6bb-4f2e-b0bc-ebc8d37d80a3 GET /v1/drugs/13397207-a6bb-4f2e-b0bc-ebc8d37d80a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Human Von Willebrand Factor",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about human von willebrand factor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.